Classifying risk factors for dyskinesia in Parkinson's disease.
about
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-studyMarkers of disease severity are associated with malnutrition in Parkinson's disease.Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype.Modern treatment in Parkinson's disease, a personal approach.Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.The relevance of gender in Parkinson's disease: a review.The impact of early versus late levodopa administration.Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias.Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.The future of pharmacogenetics in Parkinson's disease treatment.Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.Gender effect on time to levodopa-induced dyskinesias.
P2860
Q35846382-736A5EB3-8457-4E42-8AFC-5AD7DAA08433Q36721175-F97C7EBC-CC42-4799-B41A-5A5D840695C4Q38260093-E4B6F365-2565-4CFC-B682-42F048762E56Q38570529-42C41952-FBBB-42AC-9616-B9F300F86897Q38811387-5D483F2D-8DF3-4ADC-AADF-77E9C7EA74CFQ39039214-FFA44F43-815C-4A14-8561-C059035CB2FCQ39076176-B62A73C4-6EDD-4B4D-B7AD-2646FA2179BCQ39324877-46C3F0FB-D866-4021-AFB3-4B614290433EQ40860918-822B79B2-85FB-4FD3-8608-A3DCC9596832Q45007058-BDD5F218-45CB-4D30-A689-3347C5E9CFC5Q47615634-C163C8F9-CA0B-4E4E-9D93-9F424A907342Q47808802-C0868FB5-0078-48CD-A35D-235D079719CFQ49377361-018BBEEF-B3E0-454C-AE72-6D336F846A39Q51172907-9223463A-D361-4424-9DDB-B0612BA27E80Q51469422-CC17E622-3F79-49A1-ADEF-AEE32B653C3F
P2860
Classifying risk factors for dyskinesia in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Classifying risk factors for dyskinesia in Parkinson's disease.
@en
Classifying risk factors for dyskinesia in Parkinson's disease.
@nl
type
label
Classifying risk factors for dyskinesia in Parkinson's disease.
@en
Classifying risk factors for dyskinesia in Parkinson's disease.
@nl
prefLabel
Classifying risk factors for dyskinesia in Parkinson's disease.
@en
Classifying risk factors for dyskinesia in Parkinson's disease.
@nl
P2093
P1476
Classifying risk factors for dyskinesia in Parkinson's disease.
@en
P2093
C G Bachmann
G Linazasoro
J C Sharma
P304
P356
10.1016/J.PARKRELDIS.2010.06.003
P577
2010-07-03T00:00:00Z